Navigation Links
New PhRMA resources chock full of biopharma industry facts
Date:7/21/2017

WASHINGTON, July 21, 2017 /PRNewswire-USNewswire/ -- Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand medicines, generics and the supply chain account for 14 percent of total national health spending, with brands accounting for just half of this (7 percent)? Or that the United States accounts for two thirds of the world's venture capital investments in high-growth biopharmaceutical startups?

The biopharmaceutical industry accounts for 1 out of every 6 dollars spent on domestic R&D by US businesses.
The biopharmaceutical industry accounts for 1 out of every 6 dollars spent on domestic R&D by US businesses.

These are but a few of the facts that can be found in the 2017 Biopharmaceutical Research Industry Profile and industry chart pack, Biopharmaceuticals In Perspective released today. These annual resources share wide-ranging data points and updates on advances in treatment, research and development, market dynamics, cost sharing trends, medicine spending trends, outcomes and savings and the industry's economic impact.

Must-know industry facts include:

  • New medicines are making strides in reducing disease morbidity and mortality.
  • 74 percent of all drugs in clinical development are potentially first-in-class medicines, meaning they use a completely new approach to fighting a disease.
  • The biopharmaceutical industry's average return on equity is 16.2 percent, similar to other industries including trucking, software and construction supplies.
  • Negotiated savings on brand prescriptions are often not shared with patients who are increasingly being asked to pay more out of pocket.
  • Spending on brand prescription medicines only accounts for 7 percent of total annual healthcare spending.
  • 5 percent of the population accounts for 50 percent of US health care spending.
  • The biopharmaceutical industry accounts for 1 out of every 6 dollars spent on domestic R&D by US businesses.

View the industry profile here and the chart pack here.

This post originally appeared here: http://catalyst.phrma.org/new-phrma-resources-chock-full-of-biopharma-industry-facts

Contact: Holly Campbell; 202-835-3460; newsroom@phrma.org

 

View original content with multimedia:http://www.prnewswire.com/news-releases/new-phrma-resources-chock-full-of-biopharma-industry-facts-300492119.html


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America (PhRMA)
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. PhRMA Launches "Im Not Average" Campaign to Highlight the Stories of Cancer Survivors
2. PhRMA Foundation Launches New Web Platform to Support Researchers in Developing Life-Saving, Cost-Effective Medicines
3. Week in Review: The Latest from PhRMA
4. PhRMA Foundation Announces New Young Investigator Grantees to Advance Medication Adherence Research
5. Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman
6. PhRMA Applauds 2015 We Work For Health Champion Award Winners
7. PhRMA Member Companies Invested $51.2 Billion in R&D in 2014
8. National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity
9. PhRMA Elects New Members of Board of Directors
10. PhRMA and Epilepsy Foundation Report More Than 400 Medicines in Development to Treat Neurological Disorders
11. Joint BIO/PhRMA Statement on PDUFA Reauthorization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... 2017 AccuGenomics, Inc., a diagnostic company based ... that the company has provided an AccuKit to the ... at Chapel Hill and to Qura Therapeutics for evaluation ... quantify HIV reservoir and viral expression in human CD4+ ... Cure Center is a joint initiative between the University ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, announced ... comparisons, unless otherwise noted, are to the quarter ended June ... Quarter 2017 Highlights include: Revenue of ... Total prescriptions dispensed of 220,000, compared to ... Gross profit per prescription dispensed of ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Any Lab Test ... The company ranked #4429 on the newly released, 36th annual Inc. 5000 , ... unique look at the most successful companies within the American economy’s most dynamic segment ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... of their recently launched community enrichment program. Partnering once again with Boys & ... Superstar competition to help find the area’s very own American Idol. With all ...
(Date:8/16/2017)... PA (PRWEB) , ... August 16, 2017 , ... A ... it has successfully opened clubfoot clinics in all 29 Indian states—bringing the country one ... clinic in Kangra, Himachal Pradesh, the nonprofit organization is on track to enroll 10,000 ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... company based in Vero Beach, announced today that two of their associates were ... that represents professionally managed senior living communities in Florida. The awards were announced ...
(Date:8/16/2017)... ... August 16, 2017 , ... The ... men and women to train as hospice volunteers. Volunteers provide much needed joy, ... over 30 years, the agency has trained volunteers to be vital members of ...
Breaking Medicine News(10 mins):